AstraZeneca is providing Hands-On Training at Acute & General Medicine.
This promotional workshop has been organised and funded by AstraZeneca to provide a practical guidance on the use of a medicine to support the management of DOAC related bleeds.
AstraZeneca is providing Hands-On Training at Acute & General Medicine.
This promotional workshop has been organised and funded by AstraZeneca to provide a practical guidance on the use of a medicine to support the management of DOAC related bleeds.
AstraZeneca is providing Hands-On Training at Acute & General Medicine.
This promotional workshop has been organised and funded by AstraZeneca to provide a practical guidance on the use of a medicine to support the management of DOAC related bleeds.
We will review the historical framework of asthma care. We will then understand the biology behind the new asthma medications and review the evidence base as to how they work. This will allow us to understand how a biology driven approach will allow the general physician to appropriately refer high risk patients and also limit harm causing steroids.
This talk will provide an overview of the epidemiology of drug use in the UK, trends in the use of New Psychoactive Substances (NPS), and the assessment and management of patients with acute recreational drug / NPS toxicity.
Like in my talk last year I will talk about what Rural General Hospitals are, what sets them apart from a large teaching hospital and how we cope with specific issues unique to us as well as issues affecting the NHS in general. I hope I will be able to encourage colleagues to consider a career in a Rural General Hospital.
An interactive session about a bedside tool to assess Lung recruitability. Visitors will be able to perform Live lung assessments and analyse the data with our support.
An interactive session about a bedside tool to assess Lung recruitability. Visitors will be able to perform Live lung assessments and analyse the data with our support.
An interactive session about a bedside tool to assess Lung recruitability. Visitors will be able to perform Live lung assessments and analyse the data with our support.
An interactive session about a bedside tool to assess Lung recruitability. Visitors will be able to perform Live lung assessments and analyse the data with our support.
Can Bronchoscopy become a generic skill in acute care like Echocardiography and ultrasound?. How well is it performed in the ICU? Is there a training gap, and how can we use AI to help us?
This talk will provide a practical overview of the management of cardiovascular instability relating to calcium channel blocker, beta-blocker and digoxin toxicity.
Infective Endocarditis (IE) was investigated in a study at University Hospital Southampton (UHS). The research analyzed data from 282 IE patients over a three-year period, aiming to evaluate duration of diagnosis, incidence of mortality and embolic complications. The data highlights a discrepancy between time for diagnosis between Cardiology and the entire cohort, secondary to the complexity of cases admitted under Cardiology. A multidisciplinary 'Endocarditis team' was advocated by international guidelines to expedite diagnosis and treatment. UHS observed a upper limit of expected embolic risk and mortality rate, underscoring the need for an IE team. Consequently, a proposal for an IE MDT was accepted, with the view to improve patient outcomes.
When seeing frail older people presenting with falls it is essential that we consider bone health and undertake a comprehensive multiprofessional and multidomain assessment.
New guidelines have been developed to identify when individuals are at high risk of future falls and fractures.
It is recognised that there are more than 300 risk factors for falls thus an approach to a multifactorial falls risk will be discussed and shared with a real world case.
Functional illnesses and Medically Unexplained symptoms crop up in every specialty, and is reported as accounting for 10% of all NHS costs for working age people. Traditionally secondary care clinicians approach patients with functional illness by excluding other more serious conditions, reassuring the patient and sending them on their way. Making a diagnosis is important, describing a known condition as well as excluding other conditions, but often this is where our involvement ceases. There is increasing evidence of the role of Psychological input but also neurophysiological approaches to treatment.
A world leader in hemodynamic monitoring products, Edwards Lifesciences shares some of its exciting new innovations. We'll discuss the ability to predict impending hypotension, to monitor continuous oxygenation and hemoglobin and measure cardiac output non invasively, this will be an opportunity for delegates to get involved with the technology and see it in action.
A world leader in hemodynamic monitoring products, Edwards Lifesciences shares some of its exciting new innovations. We'll discuss the ability to predict impending hypotension, to monitor continuous oxygenation and hemoglobin and measure cardiac output non invasively, this will be an opportunity for delegates to get involved with the technology and see it in action.
A world leader in hemodynamic monitoring products, Edwards Lifesciences shares some of its exciting new innovations. We'll discuss the ability to predict impending hypotension, to monitor continuous oxygenation and hemoglobin and measure cardiac output non invasively, this will be an opportunity for delegates to get involved with the technology and see it in action.
A world leader in hemodynamic monitoring products, Edwards Lifesciences shares some of its exciting new innovations. We'll discuss the ability to predict impending hypotension, to monitor continuous oxygenation and hemoglobin and measure cardiac output non invasively, this will be an opportunity for delegates to get involved with the technology and see it in action.
A world leader in hemodynamic monitoring products, Edwards Lifesciences shares some of its exciting new innovations. We'll discuss the ability to predict impending hypotension, to monitor continuous oxygenation and hemoglobin and measure cardiac output non invasively, this will be an opportunity for delegates to get involved with the technology and see it in action.
A world leader in hemodynamic monitoring products, Edwards Lifesciences shares some of its exciting new innovations. We'll discuss the ability to predict impending hypotension, to monitor continuous oxygenation and hemoglobin and measure cardiac output non invasively, this will be an opportunity for delegates to get involved with the technology and see it in action.
A world leader in hemodynamic monitoring products, Edwards Lifesciences shares some of its exciting new innovations. We'll discuss the ability to predict impending hypotension, to monitor continuous oxygenation and hemoglobin and measure cardiac output non invasively, this will be an opportunity for delegates to get involved with the technology and see it in action.
A world leader in hemodynamic monitoring products, Edwards Lifesciences shares some of its exciting new innovations. We'll discuss the ability to predict impending hypotension, to monitor continuous oxygenation and hemoglobin and measure cardiac output non invasively, this will be an opportunity for delegates to get involved with the technology and see it in action.
A world leader in hemodynamic monitoring products, Edwards Lifesciences shares some of its exciting new innovations. We'll discuss the ability to predict impending hypotension, to monitor continuous oxygenation and hemoglobin and measure cardiac output non invasively, this will be an opportunity for delegates to get involved with the technology and see it in action.
A world leader in hemodynamic monitoring products, Edwards Lifesciences shares some of its exciting new innovations. We'll discuss the ability to predict impending hypotension, to monitor continuous oxygenation and hemoglobin and measure cardiac output non invasively, this will be an opportunity for delegates to get involved with the technology and see it in action.
A world leader in hemodynamic monitoring products, Edwards Lifesciences shares some of its exciting new innovations. We'll discuss the ability to predict impending hypotension, to monitor continuous oxygenation and hemoglobin and measure cardiac output non invasively, this will be an opportunity for delegates to get involved with the technology and see it in action.
A world leader in hemodynamic monitoring products, Edwards Lifesciences shares some of its exciting new innovations. We'll discuss the ability to predict impending hypotension, to monitor continuous oxygenation and hemoglobin and measure cardiac output non invasively, this will be an opportunity for delegates to get involved with the technology and see it in action.
Blood transfusions carry significant risk of complications, especially TACO hence it is necessary to avoid unnecessary blood transfusions and use restrictive targets while transfusing. Where significant disparities in practice exist, it is necessary that blood transfusion targets are revisited frequently and regular audits are undertaken to improve compliance with the standardised targets.
Project leads: Lucy Powley, Sean Botham and Alison Colhoun
The presentation will cover how we engaged multiple staff groups to change an ingrained practice of not giving patients oral medications if they are nil by mouth for theatre. Firstly, I will cover how we investigated the extent of the problem by analysing documentation. Then how we looked into the causes of the issue by engaging with ward staff and conducting a survey. How those causes were analysed and how the information was used to produce a number of interventions. Those interventions were deployed and then how we measured their effect.
These methodologies are reproducible, as are the interventions and could be applied to a variety of patient safety issues. Our interventions led to a significant improvement in the number of patients having their medicines given appropriately in the perioperative period.
I will present work from an ongoing quality improvement project which aims to increase compliance with national guidance surrounding the peri-operative use of SGLT2 inhibitors.
Delegates will learn how to prepare and interpret the Smart navigation tool to their advantage, enhancing needle visualisation and improving first-time target success rates with needle-tip trajectory foresight, enhancing the confidence of patient and practitioner.
Safe, Easy, Precise.
Delegates will learn how to prepare and interpret the Smart navigation tool to their advantage, enhancing needle visualisation and improving first-time target success rates with needle-tip trajectory foresight, enhancing the confidence of patient and practitioner.
Safe, Easy, Precise.
Delegates will learn how to prepare and interpret the Smart navigation tool to their advantage, enhancing needle visualisation and improving first-time target success rates with needle-tip trajectory foresight, enhancing the confidence of patient and practitioner.
Safe, Easy, Precise.
Delegates will learn how to prepare and interpret the Smart navigation tool to their advantage, enhancing needle visualisation and improving first-time target success rates with needle-tip trajectory foresight, enhancing the confidence of patient and practitioner.
Safe, Easy, Precise.
Delegates will learn how to prepare and interpret the Smart navigation tool to their advantage, enhancing needle visualisation and improving first-time target success rates with needle-tip trajectory foresight, enhancing the confidence of patient and practitioner.
Safe, Easy, Precise.
Delegates will learn how to prepare and interpret the Smart navigation tool to their advantage, enhancing needle visualisation and improving first-time target success rates with needle-tip trajectory foresight, enhancing the confidence of patient and practitioner.
Safe, Easy, Precise.
Delegates will learn how to prepare and interpret the Smart navigation tool to their advantage, enhancing needle visualisation and improving first-time target success rates with needle-tip trajectory foresight, enhancing the confidence of patient and practitioner.
Safe, Easy, Precise.
Delegates will learn how to prepare and interpret the Smart navigation tool to their advantage, enhancing needle visualisation and improving first-time target success rates with needle-tip trajectory foresight, enhancing the confidence of patient and practitioner.
Safe, Easy, Precise.
Delegates will learn how to prepare and interpret the Smart navigation tool to their advantage, enhancing needle visualisation and improving first-time target success rates with needle-tip trajectory foresight, enhancing the confidence of patient and practitioner.
Safe, Easy, Precise.
Delegates will learn how to prepare and interpret the Smart navigation tool to their advantage, enhancing needle visualisation and improving first-time target success rates with needle-tip trajectory foresight, enhancing the confidence of patient and practitioner.
Safe, Easy, Precise.
Delegates will learn how to prepare and interpret the Smart navigation tool to their advantage, enhancing needle visualisation and improving first-time target success rates with needle-tip trajectory foresight, enhancing the confidence of patient and practitioner.
Safe, Easy, Precise.
Delegates will learn how to prepare and interpret the Smart navigation tool to their advantage, enhancing needle visualisation and improving first-time target success rates with needle-tip trajectory foresight, enhancing the confidence of patient and practitioner.
Safe, Easy, Precise.
“Instilling a Culture of Debriefing Post Cardiac Arrest: A Quality Improvement Project” addresses the crucial issue of debriefing following cardiac arrests, emphasising the emotional and psychological impacts on healthcare providers. The project has successfully established a supportive environment by implementing debriefing through promoting effective practices and educating healthcare professionals.
This session will focus on key conditions, such as hypertension, heart failure, and mental health crises and the evidence (or lack thereof) for how to prescribe for older adults and those living with frailty. It will cover key dug-drug and drug-condition interactions, which parts of the evidence base are relevant for older adults, and the benefits and drawbacks of deprescribing.
This talk will provide an update on medico-legal issues relevant to hospital doctors in 2023 and beyond, including recent updates to GMC guidance and in relation to ‘professional standards and patient safety’.
This session will use clinical case studies to explore the interface between acute medicine and palliative care in managing patients presenting with emergency complications of their underlying condition.
This talk will cover the definition and epidemiology of polypharmacy, explore why polypharmacy is important, delve into pharmacokinetics and pharmacodynamics, cover why patients end up with excessive polypharmacy, review adverse drug reactions and the prescribing cascade, explore good prescribing habits including going through “how to go about deprescribing” using deprescribing tools that can be used to support clinical practice, explore which medicines can be stopped in patients who are approaching the end of life and review discontinuation syndromes to watch out for.
This presentation aims to highlight the important role regional anaesthesia can play in the Day surgery setting both as sole anaesthetic and also as part of multimodal analgesia
I will be discussing the specific healthcare needs of transgender and gender diverse patients in critical care and ways we can work to improve the experiences of LGBTQ+ staff and patients.
The session will provide an overview of the progress of virtual wards and digital home care over the past three years in the NHS in England, featuring a number of examples of their use and potential in different settings, concluding with Q&A
The session will provide an overview of the progress of virtual wards and digital home care over the past three years in the NHS in England, featuring a number of examples of their use and potential in different settings, concluding with Q&A
TIA is common and often proceeds an ischaemic stroke. Rapid assessment and initiation of secondary prevention can reduce the 90 day stroke risk by up to 80%. It is easy to miss TIAs with the risk of devastating stroke and also over diagnose TIAs leading to the harm of unnecessary longterm medication. The diagnosis is clinical and based mostly on an accurate history.
This presentation delves into the comprehensive understanding, diagnosis, and management of both common headache disorders and the crucial "headaches not to miss."
Behaviours to antibiotic prescribing are under researched in the ICU setting. They may influence trial effects due to unwanted and unmeasured variability in stop decisions. POCTs are increasingly used. They may have an important role in facilitating better stop antibiotic decisions and as an educational tool in antibiotic stewardship programmes (ASP). This will present evidence to back up these suggestions.